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OBJECTIVE—Visceral adipose tissue (VAT) is more closely
linked to insulin resistance than subcutaneous adipose tissue
(SAT). We conducted a quantitative analysis of the secretomes of
VAT and SAT to identify differences in adipokine secretion that
account for the adverse metabolic consequences of VAT.
RESEARCH DESIGN AND METHODS—We used lectin afﬁn-
ity chromatography followed by comparison of isotope-labeled
amino acid incorporation rates to quantitate relative differences
in the secretomes of VAT and SAT explants. Because adipose
tissue is composed of multiple cell types, which may contribute
to depot-speciﬁc differences in secretion, we isolated preadipo-
cytes and microvascular endothelial cells (MVECs) and com-
pared their secretomes to those from whole adipose tissue.
RESULTS—Although there were no discrete depot-speciﬁc dif-
ferences in the secretomes from whole adipose tissue, preadipo-
cytes, or MVECS, VAT exhibited an overall higher level of protein
secretion than SAT. More proteins were secreted in twofold
greater abundance from VAT explants compared with SAT
explants (59% versus 21%), preadipocytes (68% versus 0%), and
MVECs (62% versus 15%). The number of proteins in the whole
adipose tissue secretome was greater than the sum of its cellular
constituents. Finally, almost 50% of the adipose tissue secretome
was composed of factors with a role in angiogenesis.
CONCLUSIONS—VAT has a higher secretory capacity than
SAT, and this difference is an intrinsic feature of its cellular
components. In view of the number of angiogenic factors in the
adipose tissue secretome, we propose that VAT represents a
more readily expandable tissue depot. Diabetes 59:3008–3016,
2010
O
besity increases the risk of type 2 diabetes;
however, the distribution of body fat may be
more important than obesity per se (1). Vis-
ceral adiposity is associated with an increased
risk of insulin resistance (2–4), and this relationship
persists even in nonobese individuals (1). Similarly in
rodents, increased adiposity in epididymal, mesenteric,
and perinephric depots induces insulin resistance (5).
There are several differences between visceral (VAT) and
subcutaneous adipose tissue (SAT) that could account for
the link between VAT and insulin resistance, the most
obvious being anatomical location. VAT is particularly
sensitive to lipolytic stimuli and partly drains into the liver
via the portal vein. Increased ﬂux of free fatty acids from
VAT to liver may increase hepatic gluconeogenesis and
hepatic insulin resistance (6,7). Data in both humans and
rodents argue against this “portal hypothesis.” Removal of
gonadal (nonportal) adipose tissue in obese mice im-
proves insulin sensitivity (8). In humans, some studies
show a stronger association between subcutaneous ab-
dominal fat and insulin resistance (9,10). Thus, the role of
anatomical location in mediating the deleterious effects of
VAT remains unresolved.
These divergent metabolic effects may be due to intrin-
sic, cell-autonomous differences between VAT and SAT.
VAT displays higher rates of fatty acid uptake and release
with reduced antilipolytic response to insulin (11), in-
creased lipolytic response to catecholamines (12), in-
creased response to glucocorticoids with increased
lipoprotein lipase activation (13), and higher glucocorti-
coid receptor levels (14). Studies of gene expression have
found major differences between adipocytes and preadi-
pocytes from VAT and SAT (15). These data suggest
intrinsic differences between cells in VAT and SAT.
Adipose tissue is an endocrine organ secreting numer-
ous proteins (adipokines) with potent metabolic effects
(16). Metabolically beneﬁcial adipokines including leptin
and adiponectin are secreted in higher amounts from SAT
(17,18), whereas proinﬂammatory adipokines such as
RBP4, TNF-, MCP-1, IL-8, and IL-6 are increased in VAT
(19–23). It has been suggested that this differential secre-
tion of adipokines may account for the differing metabolic
consequences of visceral and subcutaneous adiposity.
However, it is unclear if these factors are secreted from
adipocytes or other cells resident in adipose tissue such as
macrophages. Whereas leptin and adiponectin are se-
creted by adipocytes, other factors including resistin,
visfatin, TNF-, IL-6, and MCP-1 are principally secreted
by macrophages (24). Therefore, the adipocyte may not be
the principal secretory component of adipose tissue.
We sought to accurately characterize the secretome of
adipose tissue and quantitatively compare the secretomes
from VAT and SAT explants. Previous studies identiﬁed
adipocyte secretory factors using 3T3-L1 cell-lines (25,26)
or primary adipocytes (27,28). These studies have several
limitations. Immortalized cell lines are unable to provide
depot speciﬁcity, and by isolating adipocytes from non-
adipose cells within adipose tissue, cross-talk between
these cells is lost. Using whole adipose tissue explants
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adipose-derived contaminating serum proteins. To circum-
vent this problem, we used comparison of isotope-labeled
amino acid incorporation rates (CILAIR) (29). Cells or
tissues are incubated with isotopically labeled amino
acids, which become incorporated into newly synthesized
proteins. This method allows quantitative assessment of
differences in protein secretion as a protein with a higher
incorporation of isotope is synthesized at a greater rate or
in greater abundance.
The quality of the secretome sample can also be dimin-
ished by contamination with cytosolic, nonsecretory pro-
teins released from damaged cells. Secreted proteins
commonly undergo N-glycosylation, whereas cytosolic
proteins do not. We exploited differential N-glycosylation,
using lectin afﬁnity chromatography (LAC) to selectively
enrich proteins targeted for secretion.
We used LAC followed by CILAIR (LAC-CILAIR) to
quantitate relative differences in the secretomes of murine
VAT and SAT. Because adipose tissue is composed of
multiple cell types, which may contribute to depot-speciﬁc
differences in secretion, we isolated preadipocytes and
microvascular endothelial cells (MVECs) and compared
their secretomes to that from whole adipose tissue. Al-
though we did not observe any discrete differences in
secretion proﬁle between each depot, VAT exhibited an
overall higher level of protein secretion than SAT, for
whole adipose tissue, preadipocytes, and MVECS. Inter-
estingly, a large proportion of the adipose tissue secre-
tome was factors that play a role in angiogenesis. The
increased production of these factors from VAT leads to
the inescapable speculation that VAT represents a more
readily expandable adipose tissue depot than SAT.
RESEARCH DESIGN AND METHODS
Materials and buffers. All tissue culture reagents were from Life Technol-
ogies unless otherwise stated.
Transfer medium. Dulbecco’s modiﬁed eagle medium (DMEM)/Ham’s F-12
1:1 containing 1% BSA and supplemented with 100 units/ml penicillin, 0.1
mg/ml streptomycin, and 0.25 g/ml amphotericin B (antibiotic–antimycotic,
Invitrogen).
SILAC medium. Low-glucose DMEM without leucine, lysine, and arginine
(Sigma Aldrich) was supplemented with 0.105 g/l leucine, 100 units/ml
penicillin, 0.1 mg/ml streptomycin, 0.0159 g/l phenol red, and 100 nmol/l
insulin (DMEM/K-/R-). Glucose was added to a ﬁnal concentration of 4.5 g/l.
“Heavy” or “medium” isotopes of arginine (Cambridge Laboratories U-
13C6
units–
15N4 arginine CNLM-539 or U-
13C6 arginine CLM-2265 0.021 g/l) and
lysine (Cambridge Laboratories U-
13C6 units-
15N2 lysine CNLM-291 or
4,4,5,5-D4 lysine CNLM-2640 0.0365 g/l) were added to produce “heavy” and
“medium” SILAC medium, respectively.
Endothelial cell growth medium. Endothelial cell growth medium (ECGM)
is low-glucose DMEM supplemented with 100 units/ml penicillin, 0.1 mg/ml
streptomycin, 20 mmol/l HEPES, 1% nonessential amino acids, 50 mmol/l
2-mercaptoethanol, 20% heat-inactivated FCS, 12 units/ml heparin, and 150
g/ml endothelial cell growth supplement (Sigma).
Endothelial cell SILAC medium. Endothelial cell SILAC medium is DMEM/
K-/R- supplemented with 20 mmol/l HEPES, 1% nonessential amino acids, and
50 mmol/l 2-mercaptoethanol. SILAC isotopes were added as above.
Preadipocyte growth medium. Preadipocyte growth medium is DMEM/
Ham’s F-12 1:1 supplemented with 100 units/ml penicillin, 0.1 mg/ml strepto-
mycin, and 10% FCS.
Animals. Male C57BL/6J mice were from Animal Resources Centre (Perth,
Australia). Animals were kept in a temperature-controlled room (22  1°C),
80% relative humidity, on a 12-h light/dark cycle with free access to food and
water. Experiments were carried out with approval of Garvan Institute Animal
Experimentation Ethics Committee, following guidelines issued by the Na-
tional Health and Medical Research Council of Australia. For each experi-
ment, 2–5 mice were used as tissue donors.
Preparation of anti-CD31 (anti-PECAM-1) antibody-coated magnetic
beads. Sheep anti-rat IgG Dynabeads (Invitrogen) were precoated with rat
anti-mouse monoclonal antibody to CD31 (PECAM-1) (BD Pharmingen)
according to the manufacturer’s instructions at a concentration of 1 g
antibody per 1  10
7 Dynabeads. Dynabeads were stored in PBS with 0.1%
BSA at 4°C at 4  10
8 beads/ml.
Adipose tissue explants. Paired VAT (epididymal) and SAT (inguinal)
depots were obtained from 6-week old C57BL/6J mice. Fat pads were
immediately transported in warm transfer medium to a tissue culture hood,
where they were placed in fresh transfer medium and minced into 1m m
3
pieces. Minced explants were rinsed in PBS and centrifuged at 250g to remove
cell debris and erythrocytes. Adipose tissue explants (200 l) were incubated
in 1 ml SILAC medium. After 48 h of incubation at 37°C in 5% CO2, conditioned
medium was collected and centrifuged at 2,000g to pellet cell debris. Lectin
afﬁnity chromatography and subsequent mass spectrometry were performed.
Preadipocyte and endothelial cell isolation and culture. Preadipocytes
and microvascular endothelial cells (MVECs) were isolated from the same
biopsies. Paired VAT and SAT depots were obtained from 6-week-old
C57BL/6J mice. Fat pads were immediately transported in warm transfer
medium to a tissue culture hood, where they were placed in fresh transfer
medium and minced into 1m m
3 pieces. Medium was removed and replaced
with fresh transfer medium containing 1 mg/ml collagenase type I and
incubated with gentle shaking at 37°C for 1 h. Adipose tissue to digest solution
ratio was 4:1. Resulting material was ﬁltered through 250 m mesh, and
adipocytes and free oil were separated from stromovascular components by
centrifugation at 250g for 5 min at room temperature. The stromovascular
pellet was resuspended, washed in PBS, and centrifuged at 250g for 5 min at
room temperature. This washing step was repeated twice. The stromovascular
pellet was resuspended and plated in 2% gelatin-coated 10 cm dishes in ECGM.
This mixed cell population was cultured for 5–6 days at 37°C in 5% CO2. Cells
were detached using 0.25% trypsin containing 3.42 mmol/l EDTA and trypsin
neutralized by addition of Hank’s balanced salt solution containing 5% FCS
(HBSS-FCS). The cell solution was centrifuged at 600g for 5 min at room
temperature. The cell pellet was resuspended in 0.5 ml HBSS-FCS and
incubated with 25 l of anti-CD31 (anti-PECAM-1) coated dynabeads for 15
min at 4°C under constant rotation. The cell/bead suspension was brought to
a total volume of 10 ml with HBSS-FCS and MVECs selected by magnet.
Nonselected cells in the wash were transferred to a fresh tube. The wash and
selection procedure was repeated ﬁve times. Selected cells were resuspended
in ECGM and transferred to 2% gelatin-coated culture dishes. After 3–5 days,
cells were routinely passaged and plated at equal density in ECGM. Nonse-
lected cells in wash medium were centrifuged at 600g for 5 min at room
temperature. The resultant pellet was resuspended in preadipocyte growth
medium and plated at equal density in 10 cm culture dishes. MVECs and
preadipocytes were grown until conﬂuent. At conﬂuence, medium was
replaced with endothelial cell SILAC medium and SILAC medium, respec-
tively. After 48 h, conditioned medium was collected and centrifuged at 2,000g
to pellet cell debris. Lectin afﬁnity chromatography and subsequent mass
spectrometry were performed.
Lectin afﬁnity chromatography. Conditioned media from paired visceral
and subcutaneous depots were mixed in 1:1 ratio, and glycoprotein puriﬁca-
tion was performed as previously described (30). Brieﬂy, MnCl2 was added to
conditioned media to a ﬁnal concentration of 1 mmol/l. Samples were
incubated overnight at 4°C under constant rotation with 50 l/ml of 50% slurry
of Concanavalin A Sepharose beads (GE Healthcare). Beads were washed
extensively with ConA binding buffer (0.5 mol/l NaCl, 0.1 mol/l Tris, 1 mmol/l
MnCl2, and 1 mmol/l CaCl2, pH 7.4). Proteins were eluted with 0.3 mol/l
methyl--D-mannopyranoside, 0.5 mol/l NaCl, 0.1 mol/l Tris, 10 mmol/l EDTA,
and 10 mmol/l EGTA, pH 7.4. Eluted proteins were precipitated using
chloroform/methanol (31).
Mass spectrometry. Peptide extraction and mass spectrometry were as
previously described (30,32) using a Waters Ultima tandem mass spectrome-
ter. Mascot distiller software (Matrix Sciences) was used for data analysis.
SwissProt database was used for protein identiﬁcation, taxonomy restricted
to Mus musculus, mass spectrometry tolerance set at 0.5 Da, and mass
spectrometry/mass spectrometry tolerance set at 0.05 Da. A minimum ion
score of 60 was chosen as the criterion for positive identiﬁcation. “Heavy
(U-
13C6 units-
15N4 arginine, U-
13C6 units-
15N2 lysine) to light (naturally
occurring lysine and arginine)” (H/L) and “medium (U-
13C6 arginine, 4,4,5,5-D4
lysine) to light” (M/L) isotope ratios were used to determine relative abun-
dance of proteins from visceral or subcutaneous samples, respectively. As
visceral and subcutaneous samples are mixed, nonlabeled proteins form a
“common denominator” that both isotopes are measured against (Fig. 1).
Isotope ratios below 0.05 were discounted as “no label incorporation.” Signal
peptides were determined using SignalP 3.0 (33).
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We hypothesized there would be differences in protein
secretion from VAT and SAT. Adipose tissue explants from
epididymal (VAT) and inguinal (SAT) depots were incu-
bated for 48 h in the presence of “heavy” and “medium”
isotopes of arginine and lysine, respectively. Medium was
collected, mixed in equal ratio, and subjected to LAC.
Proteins were precipitated, resolved by SDS-PAGE, tryp-
sin-digested, and subjected to quantitative mass spectrom-
etry (Table 1 and supplementary data available in an
online appendix at http://diabetes.diabetesjournals.org/
cgi/content/full/db10-0483/DC1). A total of 145 proteins
were identiﬁed, of which 86 (60%) were predicted to
contain an NH2-terminal signal peptide using SignalP. Of
these, 51 proteins (59%) were present at 2-fold higher
abundance in conditioned medium from VAT than SAT,
whereas only 18 proteins (21%) were at 2-fold higher
abundance in conditioned medium from SAT than VAT.
The frequency distribution of the visceral-to-subcutaneous
ratio for detected proteins is shown in Fig. 2A. Proteins
without a signal peptide are nonspeciﬁcally released,
newly synthesized cytosolic proteins. The distribution for
these background proteins with no signal peptide resem-
bles a normal distribution, whereas the distribution for
proteins with a signal peptide is skewed to the right. This
indicates that release of true secretory proteins into con-
ditioned medium is increased from VAT relative to SAT.
The normal distribution of nonsecretory background pro-
teins indicates a similar amount of tissue was present in
VAT and SAT samples.
Clustering analysis of detected proteins was performed
using the database for annotation, visualization, and inte-
grated discovery (DAVID) (34,35). Analysis of proteins
increased from VAT revealed enrichment of proteins in-
volved in endopeptidase inhibition, including members of
the Serpin family, and proteins involved in innate immune
system regulation, including members of the complement
pathway. Cluster analysis of proteins increased from SAT
showed no functional similarities.
Adipose tissue is composed of adipocytes as well as
preadipocytes, MVECs, and macrophages, collectively re-
ferred to as the stromovascular fraction. Stromovascular
cells may make a signiﬁcant contribution to the secretory
capacity of white adipose tissue, perhaps even exceeding
that of adipocytes (36). Interplay between cells of the
stromovascular fraction and adipocytes may also modu-
late the secretion proﬁle of adipose tissue. We sought to
determine the relative contribution of preadipocytes and
MVECs to the whole adipose tissue secretome. In addition,
we examined whether depot-speciﬁc differences in protein
secretion observed from whole adipose tissue explants
persisted in cells from the stromovascular fraction.
First we isolated preadipocytes from paired VAT and
SAT biopsies. Visceral and subcutaneous preadipocytes
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FIG. 1. LAC–CILAIR workﬂow for comparing protein synthesis and secretion from two different samples. Paired cell cultures or tissues are
incubated in media containing different isotopes of arginine and lysine, which are subsequently incorporated into newly synthesized and secreted
proteins. Paired conditioned media samples are mixed in equal proportions, and proteins are subjected to mass spectrometry. Incorporation of
amino acid isotopes results in a shift in molecular weight and mass to charge (m/z) ratio. Peak heights are measured, and their ratios are used
to determine relative abundance of proteins from samples a and b.
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incubation in medium containing isotopic amino acids.
Conditioned medium was analyzed as before (Table 2
and supplementary data). Preadipocytes secreted a
more limited set of proteins than minced adipose tissue.
Of 23 proteins detected, 22 were secretory proteins. Of
these, 15 were upregulated 2-fold from visceral com-
pared with subcutaneous preadipocytes. Not one pro-
tein was upregulated 2-fold from subcutaneous as
compared with visceral preadipocytes. The frequency
distribution of the visceral-to-subcutaneous ratio for
detected proteins is shown in Fig. 2B and is again
skewed to the right. This indicates that the release of
secretory proteins into conditioned medium is in-
creased from visceral relative to subcutaneous preadi-
pocytes. Cluster analysis of the proteins upregulated
from visceral-derived preadipocytes showed an enrich-
ment of extracellular matrix proteins.
Next, we examined MVECs isolated from paired VAT
and SAT depots. To date the secretome of endothelial cells
has not been determined. In addition, it is unknown
whether MVECs display depot-speciﬁc differences. We
isolated MVECs using CD31 magnetic bead separation and
cultured these cells in vitro. Conditioned media from cells
incubated in isotopic amino acids were collected and
analyzed as before (Table 3 and supplementary data). Of
66 detected proteins, 34 (52%) displayed an NH2-terminal
signal peptide. Of these, 21 (62%) were increased 2-fold
from visceral MVECs and only 5 were increased 2-fold
from subcutaneous MVECs. The frequency distribution of
the visceral to subcutaneous ratio for detected proteins is
shown in Fig. 2C. Once again, these data are skewed
toward increased protein secretion from visceral MVECs
(Fig. 2C). This is consistent with the enhanced secretory
capacity of VAT we have observed in both whole adipose
tissue and isolated preadipocytes. The proteins identiﬁed
include a number of proteins known to be secreted from
endothelial cells, including thrombospondin-1 and throm-
bospondin-2, and extracellular matrix proteins such as
ﬁbronectin and collagens. Additionally, several proteins
not previously known to be secreted from adipose tissue
MVECs were identiﬁed. These include the most abun-
dantly detected protein, adipocyte enhancer binding pro-
tein 1 (AEBP1). This protein inﬂuences inﬂammation in
macrophages via a direct interaction with PXR and PPAR
sites. Multiple members of the complement pathway were
also identiﬁed. Cluster analysis showed proteins more
abundantly secreted from visceral MVECs were involved
in extracellular matrix formation, including collagen and
ﬁbronectins, and endopeptidase inhibition, including
members of the Serpin family. There were no deﬁned
clusters for the ﬁve secretory proteins more abundantly
secreted from subcutaneous MVECs.
When the secretomes of whole adipose tissue ex-
plants, preadipocytes, and MVECs were compared, eight
common secreted proteins were identiﬁed (Fig. 3).
Seven secreted proteins were shared between the whole
adipose tissue and MVEC secretomes, and four were
shared between the whole adipose tissue and preadipo-
cyte secretomes. These shared proteins included pro-
teins involved in extracellular matrix formation, such as
collagen and ﬁbronectin, and other known adipocyte
proteins known such as osteonectin. Interestingly, these
data suggest the majority of proteins in the whole
adipose tissue secretome are secreted either by adipo-
cytes themselves or by other cells in the stromovascular
fraction such as macrophages and neurons. To interro-
gate this further, we compared the secretome of whole
adipose tissue explants to the secretomes of differenti-
ated 3T3-L1 adipocytes (30) and isolated rat adipocytes
TABLE 1
Comparative secretion of proteins identiﬁed from visceral and subcutaneous white adipose tissue explants
Description Signal peptide? Functional description Accession
Complement C3  Complement cascade, innate immunity CO3_MOUSE
-2-macroglobulin  Serine protease inhibitor, prevents coagulation and ﬁbrinolysis A2M_MOUSE
Laminin subunit 	-1  Extracellular matrix LAMB1_MOUSE
Laminin subunit -1  Extracellular matrix LAMC1_MOUSE
Laminin subunit -2  Extracellular matrix LAMA2_MOUSE
Collagen -1(XIV) chain  Extracellular matrix COEA1_MOUSE
Fibronectin  Extracellular matrix FINC_MOUSE
Carboxylesterase 3  Lipase CES3_MOUSE
Haptoglobin  Haem binding protein, acute phase reactant HPT_MOUSE
Collagen -2(I) chain  Extracellular matrix CO1A2_MOUSE
Serotransferrin  Iron binding TRFE_MOUSE
Laminin subunit 	-2  Extracellular matrix LAMB2_MOUSE
Complement factor B  Complement cascade, innate immunity CFAB_MOUSE
Ceruloplasmin  Copper, iron binding CERU_MOUSE
Serine protease inhibitor A3N  Trypsin inhibitor SPA3N_MOUSE
Serine protease inhibitor A3K  Trypsin inhibitor, also known as contrapsin SPA3K_MOUSE
Liver carboxylesterase N  Drug detoxiﬁcation ESTN_MOUSE
Gelsolin  Depolymerises extracellular actin from necrotic cells GELS_MOUSE
Complement C4-B  Complement cascade, innate immunity CO4B_MOUSE
Nidogen-2  Extracellular matrix NID2_MOUSE
Cathepsin B  Protease activity CATB_MOUSE
Antithrombin-III  Serine protease inhibitor, regulation of blood coagulation ANT3_MOUSE
Decorin  Extracellular matrix PGS2_MOUSE
Visceral or subcutaneous WAT explants were incubated in media containing different isotopes of arginine and lysine. Conditioned media were
mixed, subjected to lectin afﬁnity chromatography, and subjected to quantitative mass spectrometry. Peak height ratios of isotope to
endogenous (
12C) amino acids and ratios between isotopes are shown. Complete dataset available in supplementary data.
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tissue secretome, 26 were shared with the 3T3-L1 adi-
pocyte secretome and 21 were shared with the isolated
rat adipocyte secretome (Fig. 4). These data conﬁrm
that adipocytes alone are not the principal source of
secreted proteins. It is possible that other cells types in
the stromovascular fraction such as macrophages and
neurons are the source of secreted proteins. To interro-
gate this further, we compared the secretome of whole
adipose tissue explants to the secretome of human
macrophages, and only three common proteins were
identiﬁed (37).
DISCUSSION
In this study, we have made three important observations.
First, the overall secretory capacity of VAT is considerably
higher than SAT, and second, this enhanced secretory
capacity of VAT extends to cells of the stromovascular
fraction—preadipocytes and MVECs. Third, adipose tissue
as a whole secretes more proteins than its individual
component parts, suggesting the adipocyte is not the
principal secretory component of adipose tissue. The
secretome of adipose tissue is likely due to the complex
interplay between its component cell types.
To interrogate the adipose tissue secretome, we com-
bined two techniques, CILAIR (29) and LAC (30). Using
this streamlined method excluded contaminating proteins
from entrapped serum and intracellular contents from
damaged cells. Metabolic labeling identiﬁes proteins that
are newly synthesized during the culture period. Proteins
already in the secretory pathway will remain unlabeled as
will contaminants from serum and cell debris (38). LAC
selectively enriches for proteins targeted for secretion,
thus overcoming contamination from dead or damaged
cells. Abundant serum proteins, such as albumin, that are
nonglycosylated are removed. This obviates the need for
multiple washing steps to dilute these contaminating se-
rum proteins, decreasing sample processing time and the
negative impact of prolonged tissue handing. Despite
these measures, unlabeled proteins will remain in the
medium. As conditioned media from visceral and subcu-
taneous samples are mixed, nonlabeled (“light”) proteins
form a “common denominator” that both isotopes are
measured against. This eliminates any potential confound-
ing from unlabeled contaminants differentially distributed
between the two depots. The technique of LAC–CILAIR is
a useful and valid tool for interrogation of the adipose
tissue secretome, indicated by the detection of well-
known adipokines including adiponectin, adipsin, and
plasminogen activator inhibitor-1 (PAI-1).
First, we compared rates of protein secretion from VAT
and SAT explants. VAT explants secreted quantitatively
more proteins than SAT. Of proteins secreted in 2-fold
abundance, 59% were from VAT explants compared with
21% from SAT explants. This upregulation of protein
secretion from VAT was consistent across cells of the
stromovascular fraction with 68% of proteins secreted in
2-fold abundance from VAT preadipocytes compared
with 0% from SAT and 62% of proteins secreted in 2-fold
abundance from VAT MVECs compared with 15% from
SAT (Table 4). Preadipocytes and MVECs were cultured in
vitro for at least one week prior to application of labeled
media so were no longer subject to paracrine inﬂuences
from their depot of origin. This suggests increased protein
secretion is an intrinsic characteristic of components of
VAT. The detection of a small number of proteins secreted
in twofold greater abundance from subcutaneous depots
provides evidence that our technique does not selectively
detect enhanced protein secretion from the visceral depot.
Cluster analysis of proteins secreted in greater abun-
dance from VAT revealed members of the acute phase
response and innate immune system. These data raise two
interesting hypotheses. The ﬁrst is that VAT is more
pro-angiogenic than SAT, as many members of the acute
phase response, for example, haptoglobin (39), and innate
immune system (40) are involved in angiogenesis. The
capacity for angiogenesis is a crucial requirement for
adipose tissue expansion, and cells of the adipose tissue
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FIG. 2. A: White adipose tissue (WAT) explants secretory proteins are
secreted in greater amounts from VAT. B: Preadipocyte secreted
proteins are secreted at greater amounts from visceral-derived prea-
dipocytes. C: Endothelial cell secretory proteins are secreted at
greater amounts from visceral-derived endothelial cells. WAT ex-
plants, preadipocytes, and microvascular endothelial cells from vis-
ceral and subcutaneous WAT depots were cultured in media containing
two different isotopes of arginine and lysine. LAC–CILAIR mass spec-
trometry was performed, and isotopic ratios were calculated. The
histogram shows distribution of visceral-to-subcutaneous ratios for
proteins detected. Note the use of the natural log scale.
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pocytes and endothelial cells and vice versa (41). Anti-
angiogenic agents have been proposed as novel
therapeutic options in obesity as they induce weight loss
in obese mouse models without adverse effect (42). In
support of this hypothesis, cluster analysis of the 14
TABLE 2
Comparative secretion of proteins identiﬁed from visceral and subcutaneous adipose tissue–derived preadipocytes
Description Signal peptide? Functional description Accession
Collagen -1(I) chain  Extracellular matrix CO1A1_MOUSE
Collagen -2(I) chain  Extracellular matrix CO1A2_MOUSE
Collagen -1(III) chain  Extracellular matrix CO3A1_MOUSE
Collagen -2(V) chain  Extracellular matrix CO5A2_MOUSE
Fibronectin  Extracellular matrix FINC_MOUSE
Fibulin-2  Extracellular matrix FBLN2_MOUSE
SPARC  Angiogenesis inhibitor SPRC_MOUSE
Pigment epithelium-derived factor  Angiogenesis inhibitor, role in insulin resistance PEDF_MOUSE
Collagen -1(V) chain  Extracellular matrix CO5A1_MOUSE
Haptoglobin  Haem binding protein, acute phase reactant HPT_MOUSE
Cathepsin B  Protease activity CATB_MOUSE
Plasma protease C1 inhibitor  Inhibits C1s and C1r protease activity IC1_MOUSE
Plasminogen activator inhibitor 1  Serine protease inhibitor, inhibits matrix
metalloproteinases, associated with insulin resistance
PAI1_MOUSE
Collagen -1(II) chain  Extracellular matrix CO2A1_MOUSE
Metalloproteinase inhibitor 1  Regulation of extracellular matrix TIMP1_MOUSE
Collagen -1(IV) chain  Extracellular matrix CO4A1_MOUSE
Titin - Mechanical contraction TITIN_MOUSE
Biglycan  Extracellular matrix PGS1_MOUSE
Cathepsin L1  Cysteine protease CATL1_MOUSE
Epidermal growth factor receptor  Regulation of growth and proliferation EGFR_MOUSE
Collagen -2(XI) chain  Extracellular matrix COBA2_MOUSE
Follistatin-related protein 1  Growth factor binding FSTL1_MOUSE
A disintegrin and metalloproteinase
with thrombospondin motifs 7  Regulation of extracellular matrix ATS7_MOUSE
Visceral or subcutaneous WAT-derived preadipocytes were incubated in media containing different isotopes of arginine and lysine.
Conditioned media were mixed, subjected to lectin afﬁnity chromatography, and subjected to quantitative mass spectrometry. Peak height
ratios of isotope to endogenous (
12C) amino acids and ratios between isotopes are shown. Complete dataset available in supplementary data.
TABLE 3
Comparative secretion of proteins identiﬁed from visceral and subcutaneous adipose tissue–derived endothelial cells
Description
Signal
peptide? Functional description Accession
Tenascin  Extracellular matrix TENA_MOUSE
Adipocyte enhancer-binding protein 1  Transcriptional repressor AEBP1_MOUSE
Collagen -2(I) chain  Extracellular matrix COL1A2_MOUSE
Thrombospondin-1  Angiogenesis inhibitor TSP1_MOUSE
Plasma protease C1 inhibitor  Inhibits C1s and C1r protease activity IC1_MOUSE
EMILIN-1  Extracellular matrix EMIL1_MOUSE
Biglycan  Extracellular matrix PGS1_MOUSE
Collagen -1(I) chain  Extracellular matrix CO1A1_MOUSE
Basement membrane-speciﬁc heparan
sulfate proteoglycan core protein  Extracellular matrix PGBM_MOUSE
Decorin  Extracellular matrix PGS2_MOUSE
Collagen -1(III) chain  Extracellular matrix CO3A1_MOUSE
Plasminogen activator inhibitor 1  Serine protease inhibitor, inhibits matrix metalloproteinases,
associated with insulin resistance
PAI1_MOUSE
Titin - Mechanical contraction TITIN_MOUSE
14-3-3 protein 
/ - Phosphoprotein binding, modulation of enzymatic activity 1433Z_MOUSE
-2-macroglobulin  Serine protease inhibitor, prevents coagulation and ﬁbrinolysis A2M_MOUSE
Lipoprotein lipase  Lipoprotein associated lipid hydrolysis LIPL_MOUSE
	-actin-like protein 2 - Cytoskeleton ACTBL_MOUSE
Apolipoprotein E  Lipid transport APOE_MOUSE
Inter--trypsin inhibitor heavy chain
H3  Serine protease inhibitor ITIH3_MOUSE
Histone H2B type 1-C/E/G - DNA binding H2B1C_MOUSE
Visceral or subcutaneous WAT-derived endothelial cells were incubated in media containing different isotopes of arginine and lysine.
Conditioned media were mixed, subjected to lectin afﬁnity chromatography, and subjected to quantitative mass spectrometry. Peak height
ratios of isotope to endogenous (
12C) amino acids and ratios between isotopes are shown. Complete dataset available in supplementary data.
S.L. HOCKING AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, DECEMBER 2010 3013proteins secreted more abundantly from visceral preadi-
pocytes revealed proteins involved in extracellular matrix
production. This, together with our ﬁnding that VAT
secretes pro-angiogenic factors, suggests that visceral
preadipocytes are better adapted for rapid adipose tissue
expansion than subcutaneous preadipocytes. The second
hypothesis is that VAT secretes proinﬂammatory cyto-
kines. This is consistent with recent data that VAT, partic-
ularly in obesity, develops chronic low-grade inﬂammation
with macrophage inﬁltration. This is associated with insu-
lin resistance. Proteins involved in macrophage recruit-
ment were secreted in greater abundance from visceral
MVECs. This suggests that adipose tissue MVECs play a
pivotal role in enticing circulating macrophages into adi-
pose tissue. However, adipose tissue used for this study
was derived from young, lean animals. In this setting, the
upregulation of these cytokines is more likely targeted for
angiogenesis and adipose tissue proliferation rather than a
proinﬂammatory milieu. Furthermore, recruitment of mac-
rophages into adipose tissue is not always associated with
inﬂammation as macrophages in adipose tissue from lean
mice express IL-10, which protects adipocytes from insu-
lin resistance (43).
This study represents the ﬁrst survey of the endothelial
cell secretome. In comparing MVECs from VAT and SAT,
signiﬁcant differences in protein secretion were demon-
strated. Among the endothelial secretome were throm-
bospondins 1, 2, and 3, known to be secreted by
endothelial cells, as well as a number of proteins not
previously documented as endothelial secreted factors.
Surprisingly, many were known adipocyte secretory pro-
teins, including growth arrest speciﬁc 6, PAI-1, periostin,
pentraxin-related protein 3, and SPARC. Of particular
interest was identiﬁcation of AEBP1, a secreted protein
proposed to act as a transcriptional repression factor
through binding of the enhancer sequence of the aP2/
FABP4 gene in adipocytes, as well as PPAR and LXR sites
in macrophages (44,45) Preadipocytes deﬁcient in AEBP1
are hyperproliferative, with enhanced adipogenesis (46).
AEBP1 can be detected in whole adipose tissue samples,
but not when adipocytes are puriﬁed from adipose tissue
(47). Given our discovery of AEBP1 secretion from endo-
thelial cells, we consider it likely that the source of AEBP1
in adipose tissue is endothelial cells. In this study, we
found that MVECs from VAT secreted far more AEBP1
TABLE 4
Summary of numbers of proteins detected and relative abun-
dance between visceral and subcutaneous adipose tissue
samples
WAT
explants
Endothelial
cells Preadipocytes
Incorporated label 145 66 23
Signal peptide 86 34 22
Signal peptide,
visceral/subcutaneous
ratio  25 1 2 1 1 5
Signal peptide,
subcutaneous/visceral
ratio  21 8 5 0
No signal peptide,
visceral/subcutaneous
ratio  22 3 1 0 1
No signal peptide,
subcutaneous/visceral
ratio  22 2 1 4 0
% of proteins identiﬁed
with signal peptide 59 52 96
% of total ion score
from signal peptide
containing proteins 88 76 99
WAT explants
67 proteins
Endothelial 
cells
16 proteins
Preadipocytes
7 proteins
8 proteins
7 proteins
3 
proteins
4 proteins
Macroglobulins, collagen, gelsolin, 
decorin, thrombospondin
Collagen, 
biglycan, PEDF
Haptoglobin, Cathepsin L1, 
fibronectin, EGF receptor
Collagens, cathepsin B, 
osteonectin, TIMP, 
PAI-1, C1 inhibitor
FIG. 3. Venn diagram showing overlapping proteins detected from
samples. A total of 116 secretory proteins were detected across all
samples. PEDF, pigment epithelial derived factor; TIMP, tissue inhib-
itor of metalloproteinase 1. The diagram was composed using 3-Venn
applet (48). (A high-quality color representation of this ﬁgure is
available in the online issue.)
WAT explants
50 proteins
3T3-L1 adipocytes
69 proteins
Rat  isolated adipocytes
55 proteins
14 proteins
10 proteins
12 proteins
7 proteins
FIG. 4. Venn diagram showing overlap of protein secretion from WAT
explants, 3T3–L1 adipocytes, and isolated rat adipocytes (from ref 27).
The 12 proteins detected in all three samples were adiponectin,
adipsin, angiotensinogen (SerpinA8), cathepsin B, cathepsin D, colla-
gen -1(IV), collagen -2(IV), complement C1s, haptoglobin, laminin
subunit -2, osteonectin, and thrombospondin-1. The diagram was
composed using 3-Venn applet (48). (A high-quality color representa-
tion of this ﬁgure is available in the online issue.)
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tant for explaining the deleterious effects of visceral
adipose tissue.
In this study, we interrogated the secretome of whole
adipose tissue and subsequently cells of the stromovascu-
lar fraction, preadipocytes and MVECs, to determine
which component of adipose tissue was principally re-
sponsible for adipokine secretion. A total of 115 proteins
were identiﬁed from these three samples, of which 67
were unique to adipose tissue explants, 16 were unique to
MVECs, and 7 were unique to preadipocytes. Eight pro-
teins were identiﬁed in all samples, including members of
the collagen family, osteonectin, metalloproteinase inhib-
itor 1, C1 esterase inhibitor, plasminogen activator inhib-
itor-1, and cathepsin B. These data suggest adipocytes
themselves or other cells in the stromovascular fraction
not interrogated in this study, including macrophages and
neurons, are the key secretory cells within adipose tissue.
When the secretome of whole adipose tissue was com-
pared with the secretomes of both differentiated 3T3-L1
adipocytes and primary rat adipocytes, only 26 (29%) and
20 (22%) common proteins, respectively, were identiﬁed.
These data infer that adipocytes alone are not the principal
source of secreted proteins in adipose tissue. As the
adipose tissue came from lean animals, the expected
number of macrophages should be low and in fact only
three secreted proteins common to the secretomes of
whole adipose tissue and human macrophages were
found. This leads to the important conclusion that the
secretome of whole adipose tissue is not simply the sum of
each of its component parts but is the result of a paracrine
interaction between the multiple cell types within adipose
tissue.
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